Prohibits state from buying any prescription drug from a drug manufacturer at price over lowest price paid for the drug by United States Department of Veterans Affairs. Exempts managed care programs funded through Medi–Cal. Fiscal Impact: Potential for state savings of an unknown amount depending on (1) how the measure's implementation challenges are addressed and (2) the responses of drug manufacturers regarding the provision and pricing of their drugs.
YES A YES vote on this measure means: State agencies would generally be prohibited from paying more for any prescription drug than the lowest price paid by the U.S. Department of Veterans Affairs for the same drug.
NO A NO vote on this measure means: State agencies would continue to be able to negotiate the prices of, and pay for, prescription drugs without reference to the prices paid by the U.S. Department of Veterans Affairs.
PRO Prop. 61, The California Drug Price Relief Act, would require all prescription drugs purchased by the State of California to be priced at or below the price paid for the same drug by the U.S. Dept. of Veterans Affairs, which pays by far the lowest price of any federal agency.
CON Experts say Prop. 61 would: increase prescription prices, reduce patient access to needed medicines, produce more bureaucracy and lawsuits that cost taxpayers millions, and hurt veterans by increasing their prescription costs. Strongly opposed by California Medical Association, California NAACP, California Taxpayers Association, Ovarian Cancer Coalition of Greater California, Veterans of Foreign Wars (VFW), Department of California. www.NoProp61.com